CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase II Study of IMC-A12 in Metastatic Uveal Melanoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01413191
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:24.291093+00:00
- Published At
- 2015-07-20T00:00:00+00:00
- Record Updated At
- 2020-02-19
- Results Posted At
- 2015-07-20
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Ciliary Body and Choroid Melanoma, Medium/Large Size", "Ciliary Body and Choroid Melanoma, Small Size", "Iris Melanoma", "Metastatic Intraocular Melanoma", "Recurrent Intraocular Melanoma", "Stage IV Intraocular Melanoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-02-19"- protocolSection.identificationModule.nctId
"NCT01413191"- protocolSection.identificationModule.officialTitle
"Phase II Study of IMC-A12 in Metastatic Uveal Melanoma"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2015-07-20"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.